Tratamiento en Osaka (Japón)

As a specialist at the clinic, Dr. Yuichi Wakabayashi (M.D., Ph.D., ABRM Diplomate) directs regenerative medicine and personally reviews every international enquiry. He has personally managed 3,000+ stem cell cases across ~20 countries and personally conducts the full treatment workflow, from mini adipose harvesting to follow-up at 1/3/6 months. The clinic’s protocols are built around ~7-week CPC cultivation with viability testing reported as 98%+ and 13 government-approved treatment plans.

As a specialist at the clinic, Dr. Eric Verdin (President of the Buck Institute for Research on Aging) is referenced in the clinic’s NAD+ discussion for why intravenous NAD+ may not reach cells effectively. In a conversation with Peter Attia on The Drive (episode #359), he highlighted NAD+’s molecular size and described breakdown into nicotinamide before cellular use. The clinic’s longevity messaging therefore leans toward oral precursors like NMN as a more workable option.

As a specialist at the clinic, Professor Takahiro Ochiya’s exosome and extracellular vesicle research directly shapes the clinic’s exosome protocols. His work focuses on microRNA and EV signaling, with collaboration rooted in his decades of EV expertise. He has also led molecular and cellular research at the National Cancer Center Research Institute in Tokyo and received the Princess Takamatsu Cancer Research Prize.